BioGaia AB (publ) (BIOGY) Expected to Announce Earnings on Thursday

BioGaia AB (publ) (OTCMKTS:BIOGY) is expected to be announcing its resultson Thursday, October 22nd. Analysts expect the company to announce earnings of $0.9040 per share and revenue of $383.54 million for the quarter.

BioGaia AB (publ) Stock Performance

BioGaia AB (publ) stock opened at $12.45 on Tuesday. BioGaia AB has a 12 month low of $9.64 and a 12 month high of $12.45. The business has a 50 day simple moving average of $12.43 and a 200-day simple moving average of $11.58.

BioGaia AB (publ) Company Profile

BioGaia AB (publ) is a Swedish health-care company that develops, markets and sells probiotic products. Its portfolio is based primarily on scientifically documented strains of Limosilactobacillus reuteri, formerly known as Lactobacillus reuteri, and is intended to support digestive and immune health.

The company offers probiotic products for infants, children and adults, including oral drops, tablets, chewable products and other formulations. Its brands and product lines include BioGaia Protectis for digestive health, BioGaia Gastrus for gastrointestinal support and BioGaia Prodentis for oral health.